Newsmeme!
Discover News you didn't know existed
Degenerative Bone Disease
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Managing aches & pains
Published July 9, 2009, 8:48 pm, The Sun
OSTEOARTHRITIS (OA) is the most common form of arthritis and it affects millions around the world. It is caused by the breakdown and eventual loss of the cartilage of the joints. Cartilage is a protein-like substance that functions as a cushion between the bones of the joints.
Medtronic launches Infuse Bone Graft to treat degenerative disc disease
Published July 8, 2009, 7:49 pm, PharmaBiz
Medtronic India has launched a novel bone graft called 'Infuse' in the country and it will be available at leading hospitals to treat a spinal condition called degenerative disc disease. The novel graft contains a recombinant human Bone Morphogenetic Protein (rhBMP-2).
The Healthiest Foods On Earth
Published July 8, 2009, 3:10 pm, Forbes
The most important consideration in constructing a healthy diet: Eat whole food with minimal processing. These 12 foods do the trick.
Work in mice will contribute to the study of hereditary diseases that lead to blindness
Published July 8, 2009, 8:20 am, PhysOrg
Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light exposure in the mouse's retina that will be helpful for the study of retinitis pigmentosa (RP), a group of hereditary diseases which lead to blindness and affect more than one million persons a year all over the world.
Griffin Securities Initiates Independent Research Coverage on Pluristem Therapeutics Inc.
Published July 8, 2009, 5:00 am, Business Wire via Yahoo! Finance
HAIFA, Israel----Pluristem Therapeutics Inc. , a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced today that Griffin Securities has initiated independent research coverage of Pluristem's stock.
Pluristem Therapeutics Announces First Patient Enrollment in Phase I Clinical Trial for Treatment of Peripheral Artery ...
Published July 7, 2009, 1:00 am, Business Wire via Yahoo! Finance
HAIFA, Israel----Pluristem Therapeutics Inc. , a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced today that the first patient has been enrolled in a Phase I clinical trial of the Company's allogeneic placental-derived adherent stromal cell product, termed PLX-PAD.
Sylvan Lake woman scheduled for experimental treatment
Published July 6, 2009, 7:51 am, Red Deer Advocate
Jessica Blunden is counting the days until she undergoes more chemotherapy and a bone marrow transplant that could send her multiple sclerosis into remission.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |